In an attempt to find out the most proper anticoagulant in blood cell counting, effects of several anticoagulants available at present time: oxalate, EDTA, heparin alone (Anticlot) and mixture of heparin and EDTA (Anticlot/ET) upon blood cells were evaluated from the view-points of quantitative and qualitative (morphologic) changes in the venous blood added with such anticoagulants observed after definite time intervals. Data of the capillary (ear-lobe) blood were used as control. Blood examination comprised hemoglobin, red blood cells, hematocrit, reticulocytes, white blood cells, platelets and leukocyte differentials on a blood smear. Examinees of each group were about 100 subjects.
1. Quantitative Studies:
Values of the anticoagulant-mixed venous blood were generally lower than those of the capillary blood. These differences, however, were statistically insignificant when oxalate, EDTA and Anticlot/ET were used as an anticoagulant. Values of the venous blood added with Anticlot were significantly lower than the control values.
Time course study revealed that no remarkable changes in hemoglobin, red blood cells, hematocrit and reticulocytes were seen as long as six hours after sampling with any kind of anticoagulants, whereas leukocytes decreased with the progression of time in all cases and platelet counts did not change in oxalated, EDTA- and Anticlot/ET-blood but Anticlot caused a remarkable decrease in platelets with the progression of time.
2. Qualitative Studies:
Morphological study revealed that several degenerative changes were seen in leukocytes on smears prepared from anticoagulated blood, most markedly from oxalated and most mildly from Anticlot/ET-blood. There was no remarkable change in red cells but a slight crenation after a long time. Platelets shrunk and were densely stained in oxalated, EDTA-, and Anticlot/ET-blood, whereas they were rather swollen with Anticlot with the time elapsed.
From the above-mentioned results it may be concluded that Anticlot/ET or EDTA is a most suitable anticoagulant for routine use when blood examination is done within two hours after sampling.
View full abstract